Orient Europharma Co

Orient Europharma Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Orient Europharma Co (4120.TWO) as of Oct 17, 2026 is 1.20. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.43 — a change of -16.51% (lower).

PEG

1.20

YoY

-16.51%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Orient Europharma Co is 2023 1.20 . PEG Ratio (Price/Earnings-to-Growth) of Orient Europharma Co was 2022 1.43 . It decreases by -16.51% lower compared to the previous year.

The Orient Europharma Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2015
0.77 TWD
Jan 1, 2016
0.37 TWD
Jan 1, 2017
0.38 TWD
Jan 1, 2018
0.70 TWD
Jan 1, 2019
0.70 TWD
Jan 1, 2020
0.86 TWD
Jan 1, 2021
1.43 TWD
Jan 1, 2023
1.20 TWD
The Orient Europharma Co PEG history
YEARPEGYoY
1.20-16.51%
1.43+65.85%
0.86+24.27%
0.70-0.38%
0.70+85.92%
0.38+2.37%
0.37-52.48%
0.77-12.21%
0.88—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd, based in Taipei City, Taiwan, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and trades western medicine, health food, and cosmetics, with a focus on nutritious healthcare products, medical cosmetic products, and western drugs. Its product segments include infant milk powders, functional healthcare items, dermatological preparations, medical hair care, organic skincare, and pharmaceuticals for conditions such as cardiovascular diseases, cancer, and diabetes. Listed on 28 November 2002. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

PEG Ratio (Price/Earnings-to-Growth) of Orient Europharma Co is 1.20 in 2023.

PEG Ratio (Price/Earnings-to-Growth) of Orient Europharma Co changed from 1.43 to 1.20, representing a -16.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Orient Europharma Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Orient Europharma Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Orient Europharma Co